In conclusion, our data indicate that patients with SLE contain higher proportions of CD3+CD4+Tim-3+ and CD3+CD4-Tim-3+ T cell subsets than HCs, and Tim-3 expression on CD3+CD4+ and CD3+CD4- T cells correlates with SLE disease activity. The gene discussed is HAVCR2; the disease is systemic lupus erythematosus.